Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Entheon Biomedical Corp (ENTBF)

Entheon Biomedical Corp (ENTBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Entheon Announces Change of Directors Newsfile - Fri Apr 4, 7:30PM CDT

Vancouver, British Columbia--(Newsfile Corp. - April 4, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces the appointment of Harrison Newlands...

ENBI.CN : 0.1050 (-12.50%)
ENTBF : 0.0770 (-4.94%)
Entheon Issues Incentive Stock Options Newsfile - Mon Mar 31, 3:30PM CDT

Vancouver, British Columbia--(Newsfile Corp. - March 31, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces that the Company has granted options...

ENBI.CN : 0.1050 (-12.50%)
ENTBF : 0.0770 (-4.94%)
Entheon Announces Termination of Mentis AI Agreement Newsfile - Fri Mar 14, 4:00PM CDT

Vancouver, British Columbia--(Newsfile Corp. - March 14, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces that, further to its news release...

ENBI.CN : 0.1050 (-12.50%)
ENTBF : 0.0770 (-4.94%)
Entheon Announces Agreement to Acquire Mentis AI Newsfile - Fri Jan 24, 9:34AM CST

Vancouver, British Columbia--(Newsfile Corp. - January 24, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") is pleased to announce that it has entered...

ENBI.CN : 0.1050 (-12.50%)
ENTBF : 0.0770 (-4.94%)
Cybin (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate CYB004 Clinical Program Investor Brand Network - Thu Aug 4, 2022

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, has completed the acquisition...

ENBI.CN : 0.1050 (-12.50%)
CYBN.NE : 9.8000 (+4.48%)
CYBN : 7.33 (-2.27%)
ENTBF : 0.0770 (-4.94%)
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders FinancialNewsMedia - Wed Jul 27, 2022

Palm Beach, FL – July 27, 2022 – For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vietnam...

ENBI.CN : 0.1050 (-12.50%)
CMPS : 4.92 (+13.10%)
CYBN.NE : 9.8000 (+4.48%)
ATAI : 1.9550 (+6.25%)
FTRP : 0.8421 (+1.07%)
CYBN : 7.33 (-2.27%)
FTRP.TO : 1.09 (+5.83%)
ENTBF : 0.0770 (-4.94%)
SILO : 0.5054 (+0.28%)
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders PR Newswire - Wed Jul 27, 2022

/PRNewswire/ -- For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many...

CMPS : 4.92 (+13.10%)
ATAI : 1.9550 (+6.25%)
FTRP : 0.8421 (+1.07%)
CYBN : 7.33 (-2.27%)
ENTBF : 0.0770 (-4.94%)
FTRP.TO : 1.09 (+5.83%)
SILO : 0.5054 (+0.28%)
Cybin (NYSE American: CYBN) (NEO: CYBN) Acquires DMT Study Investor Brand Network - Mon Jul 11, 2022

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that, through its wholly-owned subsidiary Cybin IRL Limited,...

ENBI.CN : 0.1050 (-12.50%)
CYBN.NE : 9.8000 (+4.48%)
CYBN : 7.33 (-2.27%)
ENTBF : 0.0770 (-4.94%)
Cybin Completes Acquisition of Phase 1 DMT Study from Entheon Biomedical Business Wire - Mon Jul 11, 2022

Cybin Inc. ( NEO:CYBN ) (NYSE American:CYBN) (“ Cybin ” or the “ Company ”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™”, today announced that, through...

ENBI.CN : 0.1050 (-12.50%)
CYBN.NE : 9.8000 (+4.48%)
CYBN : 7.33 (-2.27%)
ENTBF : 0.0770 (-4.94%)
Cybin Acquires DMT Clinical Study from Entheon Biomedical Business Wire - Tue Jun 7, 2022

Cybin Inc. ( NEO:CYBN ) (NYSE American:CYBN) ( Cybin or the Company ), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™”, today announced that, through its wholly-owned...

ENBI.CN : 0.1050 (-12.50%)
CYBN.NE : 9.8000 (+4.48%)
CYBN : 7.33 (-2.27%)
ENTBF : 0.0770 (-4.94%)

Barchart Exclusives

Market Bottom Alert: Corn Prices Are Rebounding and More Upside Is Likely Barchart - 10 minutes ago
More years than not, a weather scare occurs and is bullish for the corn futures market. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot